Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darvadstrocel for complex perianal fistula in pediatric Crohn's disease (Japan, jRCT2033200314)
jRCT2033200314Phase 3Completed
- Sponsor
- Takeda
- Start
- Jun 2021
- Modality
- Stem Cell Therapies → Cell Therapies
01
Overview
Phase 3, open-label, single-arm trial of darvadstrocel in Crohn's disease and anal fistula, sponsored by Takeda. Primary endpoint: Combined remission at Week 24. Started Jun 2021; status: completed.
02
Drugs
darvadstrocel
03
Conditions
Crohn's diseaseanal fistula
Beyond the preview
Go deeper on jRCT2033200314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2033200314.